An individualised treatment algorithm for tumour stage 1 glottic squamous cell carcinoma

Aydíl, Utku; Akmansu, Müge; Kızıl, Yusuf; Yazici, O.; Üstün, Selin; Karaloğlu, Furkan; Köybaşıoğlu, Ahmet

doi:10.1017/s0022215113002363

Cited by 3 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 We observed an absence of regional recurrence in patients with glottic T1 carcinoma (n 5 113). This finding is in agreement with the study by Aydil et al 27 who reported a 5-year regional recurrence rate of 1.2% in stage I glottic laryngeal SCC. According to the current Finnish protocol, approximately 400 visits would be conducted for these patients after the first 3 years of followup with no further detection of recurrences.…”

Section: Time Of Recurrencesupporting

confidence: 94%

Predictive factors and treatment outcome of laryngeal carcinoma recurrence

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Time Of Recurrencesupporting

confidence: 94%

Predictive factors and treatment outcome of laryngeal carcinoma recurrence

et al. 2016

View full text Add to dashboard Cite

show abstract

“…T1 glottic laryngeal squamous cell carcinoma (LSCC) can be treated either with trans-oral laser surgery or with radiotherapy. The prognosis is excellent regardless of the treatment method [1][2][3][4][5][6][7][8]. In Finland, LSCC is mainly treated in university hospitals.…”

Section: Introductionmentioning

confidence: 99%

T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence

Pakkanen

Ilmarinen

Halme

et al. 2021

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Purpose We assessed the treatment outcome and the benefits of routine follow-up visits in T1 glottic laryngeal squamous cell carcinoma (LSCC). Methods Medical records of patients diagnosed with stage T1 glottic LSCC (N = 303) in five Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected. Results Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year disease-specific survival (DSS) or laryngeal preservation rate. Conclusion The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems beneficial. Trial registration Trial registration number and date of registration HUS/356/2017 11.12.2017.

show abstract

“…Anterior commissure involvement has been reported in between 17.6 and 45.4 per cent of cases. However, although this is of the utmost clinical importance, it currently has no impact on laryngeal cancer staging 8 – 12 …”

Section: Larynxmentioning

confidence: 99%

Tumour–node–metastasis staging of human papillomavirus negative upper aerodigestive tract cancers: a critical appraisal

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

An individualised treatment algorithm for tumour stage 1 glottic squamous cell carcinoma

Abstract: Tumour stage 1 glottic carcinoma can be managed with different treatment modalities, following an individualised treatment algorithm, with results comparable to published outcomes.

Cited by 3 publications

References 20 publications

Predictive factors and treatment outcome of laryngeal carcinoma recurrence

Predictive factors and treatment outcome of laryngeal carcinoma recurrence

T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence

Tumour–node–metastasis staging of human papillomavirus negative upper aerodigestive tract cancers: a critical appraisal

Contact Info

Product

Resources

About